Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

FDG-PET/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients

This study has been terminated.
(Funding from the NIH ended and not all patients had been accrued)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Utah Identifier:
First received: June 25, 2008
Last updated: June 7, 2016
Last verified: June 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2010
  Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)